Contrave may join weight loss weapons in December

Weight loss medicines have not had such a good track record recently when being considered by the FDA. Yet another candidate is named Contrave and is a combination of two medicines (bupropion SR and naltrexone SR) in a single pill. The FDA expert advisory panel (Endocrine and Metabolic committee) will meet to consider this combination pill in December. 

Contact Us

Our Location

Office Hours
Monday:9:00 AM - 5:00 PM
Tuesday:9:00 AM - 5:00 PM
Wednesday:9:00 AM - 5:00 PM
Thursday:9:00 AM - 5:00 PM
Friday:9:00 AM - 5:00 PM